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The twin towers of infectious diseases were first defined 
in a rudimentary way in the latter half of the 19th cen- 
tury. These were the characteristics of disease-causing 
microorganisms and the major host defense systems 
(polymorphonuclear leukocytes and circulating antibody). 
In recent decades advances in microbiology, immunol- 
ogy, and therapeutics have kept our focus on microbes, 
host responses, treatment modalities, and the epidemi- 
ology of established infections and epidemics. Now there 
is increasing interest in attempting to predict the epi- 
demiologic patterns of various infectious diseases in 
future years or decades. This newer focus has been sub- 
sumed under the rubric of emerging and re-emerging 
infections. The definitions are somewhat overlapping. 
Emerging infections are those that are either newly 
described or, alternatively, are known but appear in new 
geographic areas or increase markedly in frequency, par- 
ticularly in compromised hosts. Re-emerging infections 
are previously well-described and either occur in new 
geographic areas or reappear in the same geographic area 
after a period of relative or complete dormancy 
The study of these infectious diseases in populations 
(as contrasted to individuals) can be broadly divided into 
two categories: 
(a) Risk factors that augment susceptibility, clinical 
manifestations, mechanisms of spread (droplet, direct 
contact, etc.), individual and population resistance, and 
control of established infections, and 
(b) Broader societal factors that promote or retard 
the appearance, spread, progression, and control of these 
infectious diseases. 
A focus on societal issues is hardly new. Poverty and 
urbanization were noted to be major factors in the spread 
of tuberculosis in the 19th century. The role of sewage- 
contaminated water in the spread of cholera was docu- 
mented clearly in 1854 by John Snow.’ Travel by infected 
individuals and urbanization as risk factors for syphilis 
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were recognized as early as the end of the 15th century 
Similarly the role of rodent reservoirs for infectious dis- 
eases and their dissemination by ships of commerce has 
long been recognized. 
Predicting the nature of infectious diseases in the 
next century will require special attention to the broader 
societal issues, because it is these that will be the decid- 
ing variables, determining which microbes will emerge 
and re-emerge, obviously influenced by our ever greater 
ability to prevent certain infections by widespread immu- 
nization. Some major variables to be considered in pre- 
dicting the frequency and severity of emerging and 
re-emerging infectious diseases are listed in Table 1. These 
are discussed briefly, and some preventive actions that 
could lessen the adverse impact of at least some of the 
promoting variables are summarized. 
The over-arching societal variable is population 
growth. The figures are daunting. In 1830, the world 
population was 1 billion. One hundred years later (1930) 
it had doubled to 2 billion. At the start of the 2 1st cen- 
tury there will be 6 billion of us, a threefold increase in 
the last 70 years. At present, world population is dou- 
bling every 43 years. By the end of the next century the 
planetary population will reach at least 10 billion, and, 
in a worst case scenario, perhaps as many as 14 billion.2,3 
Ninety-five percent of the population increase in the 2 1 st 
century will take place in so-called developing countries 
that are ill-equipped to cope with this enormous human 
burden. The final world population at the time stability 
is reached by the year 2200 is likely to be between 11 
and 20 billion. Whether it is the lower or higher figure 
depends on what happens to fertility rates in the next 
decades. 
The massive growth of world population affects 
many of the other determining variables. By the year 
2030 more than 50% of the 8 billion inhabitants of planet 
earth will be crowded into often massive urban centers, 
most with gargantuan poverty-stricken slums that are ver- 
itable breeding sites for mosquitos and flies and a variety 
of emerging and re-emerging infections. 
More people in a world in which territorial, ethnic, 
religious, and tribal issues are perpetually contentious 
almost certainly will lead to more warfare. That in turn 
means more refugees and displaced persons-refugees 
who are often malnourished, and who often live under 
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abysmal conditions and are therefore inordinately sus- 
ceptible to many infectious diseases. Additionally they 
are exposed in their travels to microbes to which they 
have inadequate immunity, and they also carry with them 
pathogens that can be introduced into susceptible 
populations. 
Population pressures require more land for agricul- 
ture; that means progressive destruction of critical rain 
forests, a destruction that increases environmental car- 
bon dioxide (CO,), the most important of the greenhouse 
gases. Increased energy and irrigation needs for a bur- 
geoning population result in massive dam construction; 
that construction is often complicated by vector redis- 
tribution with subsequent epidemics. Major increases 
have occurred particularly in the incidence of malaria 
and schistosomiasis.* 
Population growth aside, the most critical of the soci- 
etal variables is likely to be the virtually inevitable global 
warming.5,6 For decades there has been a sometimes acri- 
monious debate on the likelihood and extent of global 
warming. In the last 3 years the weight of evidence has 
produced a growing consensus that this planet will be 
1.5”C to 4.O”C warmer in the 21st century Half the green- 
house gas burden is attributable to CO,; most of more 
than 25 billion tons released annually into the environ- 
ment results from industrial and home fossil fuel use and 
from the emissions of the world’s 500 million cars and 
trucks. Although carbon dioxide is currently the most 
important greenhouse gas, in the next century methane 
(CH,) may assume that role. Methane, primarily derived 
from anaerobic bacterial activity, now accounts for 10 to 
20% of greenhouse gases, but it is far more efficient than 
CO, in trapping heat. Atmospheric concentrations are 
increasing at more than 1% annually. Swamps, peat bogs, 
rice paddies, decaying vegetation, the intestinal tracts of 
cattle and termites, oil and natural gas production, and 
coal extraction are the major planetary sources. 
Population growth and global warming are closely 
interrelated. More people require a greater energy sup- 
ply, they use more automobiles, and they own more cat- 
tle and other ruminants, all of which will markedly 
increase the greenhouse gases CO, and CH,. 
Global warming will change vector distribution, 
increase the activities of mosquitoes in some geographic 
areas and shorten the extrinsic period (the time required 
for development of infectious agents in the mosquito). 
Malaria and dengue, attacking previously uninvolved 
populations, will lead the list of infectious diseases pro- 
moted by a warmer world.7-10 Additionally the droughts 
and floods that accompany global warming will create 
vast geographic areas that will be plagued by economic 
scarcity and malnutrition, and this will result in an 
avalanche of refugees that will dwarf the current refugee 
problem. 
The variables that promote emerging and re-emerging 
infections are often viewed in isolation. That is impru- 
dent. They are often interrelated, additive, and synergis- 
tic. They must be analyzed as interconnected factors. 
The reaction by the infectious diseases community 
and by governments to the threats and presence of 
emerging and re-emerging infections can be divided into 
three approaches: 
(1) Increased surveillance. This is secondary pre- 
vention; that is, early detection. Surely that is needed.” 
Influenza is a paradigm of the effectiveness of early detec- 
tion. It allows characterization of the viruses, subsequent 
modification of vaccines in accordance with changes in 
the virus, and then intensive immunization campaigns. 
Clearly, despite burgeoning information and communi- 
cation technologies, we have a long way to go in our sur- 
veillance capabilities. In some cases, as in some recent 
Ebola outbreaks, the epidemic started in relatively remote 
or rural areas with inadequate health facilities, very lim- 
ited diagnostic capacities, and rudimentary communica- 
tions.12J4 But often, in less remote settings, diagnostic 
surveillance is inadequate; this was true in the early stages 
of the recent outbreak of plague in India.15 Surveillance 
is particularly important in refugee camps that are fertile 
areas for cholera and other epidemics. The problem of 
course is that increased surveillance requires a linked 
chain of activities from field observations and obtaining 
proper specimens to adequate diagnostic laboratory facil- 
ities, either locally or at a more distant locale (sometimes 
thousands of miles away). That kind of worldwide linked 
chain requires a continuing commitment of finances. For- 
tunately the necessary monetary commitment is relatively 
modest; therefore, it is likely that worldwide surveillance 
for emerging and re-emerging infections will continue to 
improve. Still, secondary prevention has the huge disad- 
vantage of recognizing new and re-emerging infections 
after the event has started. In some cases early inter- 
vention will minimize the damage of the epidemic; in 
other cases effective treatment will not be available, and 
more extensive damage will be inevitable. 
(2) Adequate public health infrastructure. This 
allows primary and secondary prevention as well as 
therapeutic interventions. Primary prevention currently 
consists, for the most part, of vector eradication, immu- 
nizations, and provision of uncontaminated drinking 
water. Secondary prevention is, as noted, early detection. 
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Effective therapeutic interventions require adequate med- 
ical and health personnel, as well as availability of clinics, 
hospitals, and medications. Infrastructure inadequacies 
guarantee continuing epidemics of emerging and re- 
emerging diseases. The current diphtheria epidemic in 
Russia and a large cryptosporidium epidemic in the United 
States can be attributed, at least in part, to infrastructure 
breakdowns.16J7 Effective infrastructure requires adequate 
funding, proper organization, and political will-all of 
which are frequently in woefully short supply Often the 
country’s economy limits the resources that can be com- 
mitted. Adequate infrastructure is relatively expensive. In 
the United States, annual government spending on health 
care exceeds $1000 per capita. In the majority of coun- 
tries of the world, annual government expenditures range 
from $1.00 to $20.00 per capita. Where the total com- 
mitment is $20 or less per capita, the funds usually are 
largely consumed by the bureaucracy and treatment of 
established disease. In such cases a public health infra- 
structure that could prevent emerging or re-emerging 
infections, or detect them at the start of an epidemic, will 
almost certainly be rudimentary and inadequate. 
(3) Primary prevention. Although worldwide sur- 
veillance and adequate infrastructure can play an impor- 
tant role, potentially the most effective approach is 
removal of risk factors. That brings me back to the major 
risk factors for emerging and re-emerging infections (see 
Table 1). None of these risk factors is immutable; there is 
the potential for mitigating the severity of each risk fac- 
tor listed. There is emerging evidence that education and 
condom availability help in reducing the severity of the 
AIDS epidemic.1s~19 Better controls on the prescribing of 
antibiotics will lessen problems with antimicrobial resis- 
tant strains. The technologic capacity exists to reduce 
(but not eliminate) the severity of global warming, by 
decreasing fossil fuel use, increasing use of renewable 
energy sources, and controlling industrial and automobile 
emissions. An interesting approach to reducing the prob- 
lems with infectious diseases consequent to dam con- 
struction and irrigation is to require an infectious diseases 
impact statement prior to starting construction.20 Con- 
sidering the malaria, schistosomiasis, and viral epidemics 
that have followed such construction, this would appear 
to be a constructive suggestion. 
The greatest challenge in meeting the threat of emerg- 
ing and reemerging infections will be in controlling world 
population growth. This too can be done, but it requires 
that governments around the world establish population 
control as a top priority; this has not been done. Politicians 
tend to stay as far away as possible from defining popu- 
lation control as a critical (perhaps the most important) 
world priority There must be a far greater attention to and 
support of family planning. Currently about $4 billion a 
year is spent on family planning and/or population con- 
trol in developing countries; about two thirds of that 
amount is committed by those developing countries.” 
The so-called developed countries need to increase their 
financial commitment by as much as lo-fold. In the face 
of increased need, the Congress of the United States has 
taken patently irresponsible actions to reduce the mone- 
tary contribution of the United States to international fam- 
ily planning and population control. 
Additionally there should be a sense of urgency. Our 
planet is virtually committed to a population size of 8 bil- 
lion persons by the year 2025. Twenty-five years later 
(2050) an optimistic scenario would place the projected 
population at 9 billion, a more likely prediction would be 
a population of 10 billion, and a worst case scenario 
would be 12 billion persons. If the figure is 10 billion, 
the eventual world population is likely to be about 14 bil- 
lion; if the figure is 12 billion, the population growth 
momentum is such that eventual population at stability is 
likely to be 18 to 20 billion persons. We need to act now; 
procrastination will likely be catastrophic. 
What should be the role and obligations of infectious 
diseases experts? It seems to me we must actively pro- 
mote all three approaches summarized above. Until now 
we have focused almost exclusively on surveillance and 
public health infrastructure. That is not good enough. We 
should be actively and publicly involved in primary pre- 
vention (risk reduction or removal) for the major societal 
variables I have cited. Whether we will be effective is, of 
course, uncertain, but at least we have to try, we have to 
get involved. If we do not, we will always be in the posi- 
tion of picking up the pieces for a global society unwill- 
ing to tackle major problems that relate to the likelihood 
of emerging or re-emerging infections. There is ample 
precedent for such physician activism; physicians have 
played a major role in control of nuclear weapons and 
prevention of nuclear war, in the protection of human 
rights, in the fight to reduce environmental pollution, and 
in automobile safety 
Finally, I would note that physician activism can take 
two forms. One is involvement in attempting to influence 
the societal issues that create the milieu in which emerg- 
ing and re-emerging infections flourish. The other is get- 
ting involved in the educational system so that a large 
percentage of young people finish their formal education 
(high school, college, graduate school) committed to long- 
term, part-time, or even full-time involvement in attempts 
to solve major societal problems, some of which are 
clearly related to incidence or severity of emerging or re- 
emerging infections. 
What we cannot afford to do is to pay attention only 
to microbes and hosts, to antimicrobial usage and effec- 
tiveness, and to hospital and community surveillance. We 
must assess the societal variables that will determine the 
nature and severity of infectious disease, become com- 
mitted, and act prospectively As we approach the 21st 
century that is our obligation-to our profession, to our 
children, and to our world. 
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AWARDS PRESENTED AT THE 
7TH INTERNATIONAL CONGRESS FOR INFECTIOUS DISEASES 
Hong Kong 
June 10-13, 1996 
More than 200 abstracts in the category of epidemiology of infectious diseases were reviewed by the program com- 
mittee. Of these, five abstracts were selected for recognition by the International Congress for Infectious Diseases 
(ICID) Corporate Sponsors. 
The Pasteur MCrieux-Connaught Award for Communicable Disease Epidemiology was presented to the following 
individuals: 
Marcel0 Burattini, from Slo Paulo, Brazil, for his abstract on the relationship between duration of imprisonment 
and risk of transmission of HIV/AIDS in a Brazilian prison. 
Robert M. Jacobson, from Rochester, Minnesota, USA, for his abstract on the use of meta-analysis to determine 
secondary failure rates of measles vaccines. 
Daphne Holt, from London, United Kingdom, for her abstract on a prospective study of mortality and morbid- 
ity caused by bacterial meningitis in the newborn. 
The Chiron Biocine Award for Epidemiology of Infectious Diseases was presented to the following individuals: 
Mei-Shang Ho, from Taipei, Taiwan, for her abstract on the differential risk of cervical cancer due to the inter- 
action of the host’s HLA type and multiple viral infections. 
Geoffrey Hogg, from Victoria, Australia, for his abstract on the epidemiology of invasive pneumococcal disease 
in the state of Victoria, Australia. 
